NR3C1 and breast cancer: Greater than 90% of BC CAFs, especially HR+ cancer CAFs, express the glucocorticoid receptor, with its expression correlating positively with tumor grade, Ki-67 index, and expression of the glucocorticoid receptor in the cancer cells [341].